CNS5:Pleomorphic xanthoastrocytoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 198: | Line 198: | ||
|P | |P | ||
|Yes (WHO CNS5) | |Yes (WHO CNS5) | ||
|Associated with anaplastic progression, poor recurrence-free survival, and adverse prognosis in high-grade PXA | |Associated with anaplastic progression, poor recurrence-free survival, and adverse prognosis in high-grade PXA (PMID: 35545827) | ||
|- | |- | ||
|IDH1/IDH2 | |IDH1/IDH2 | ||
|Missense (R132H, etc) | |Missense (R132H, etc) | ||
| | |Other | ||
| | |Absent in classic PXA | ||
| | |D | ||
| | |Yes (WHO CNS5 for differential diagnosis) | ||
| | |Absence confirms classic PXA; if present, suggests diffuse astrocytoma not PXA (PMID: 26414224) | ||
|- | |- | ||
| | | | ||